Related Experiment Video
Updated: Jun 25, 2026
05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
[Sentinel lymph node biopsy in gastro-intestinal surgery: facts and future implications]
1Département médico-chirurgical de pathologie digestive, hôpital Lariboisière, 2 rue Ambroise-Paré, 75010 Paris. Faculté Paris Diderot, Paris-7. marc.pocard@lrb.aphp.fr
Journal De Chirurgie
|February 6, 2009
Summary
Sentinel lymph node (SLN) biopsy shows promise in gastric and anal cancers for staging and surgical guidance. However, its reliability in colon cancer and the prognostic value of micrometastases require further investigation for broader application.
Area of Science:
- Oncology
- Surgical Pathology
Context:
- Sentinel lymph node (SLN) biopsy is a technique with theoretical applicability to all solid cancers.
- Its adoption in gastrointestinal (GI) cancer surgery remains limited despite demonstrated value in specific early-stage gastric cancers, primarily in Japan.
Purpose:
- To evaluate the current status and potential applications of SLN biopsy in gastrointestinal and anal canal cancers.
- To assess its reliability in predicting nodal status, its role in surgical planning, and its prognostic significance.
Summary:
- SLN biopsy is valuable for early-stage gastric cancer but not standard in other GI cancers.
- Studies in colon cancer have not confirmed its reliability for omitting lymph node dissection.
- SLN biopsy can aid in mapping lymphatic drainage, potentially sparing critical arteries, and can identify micrometastases, reclassifying tumors from Stage I to Stage II in 10-15% of cases.
- Its utility in anal canal cancer for guiding inguinal lymph node dissection is under investigation.
Impact:
- SLN biopsy can refine cancer staging by detecting micrometastases, impacting treatment decisions.
- It offers potential for optimizing surgical strategies, such as preserving vascular supply based on aberrant lymphatic drainage.
- Further research is needed to establish the prognostic value of micrometastases detected by advanced techniques and to validate SLN biopsy's role in colon cancer.
